Systemic Administration of AAV8-α-galactosidase A Induces Humoral Tolerance in Nonhuman Primates Despite Low Hepatic Expression
Open Access
- 1 November 2011
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 19 (11) , 1999-2011
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Unbiased, Genome-Wide In Vivo Mapping of Transcriptional Regulatory Elements Reveals Sex Differences in Chromatin Structure Associated with Sex-Specific Liver Gene ExpressionMolecular and Cellular Biology, 2010
- Preexisting Immunity and Low Expression in Primates Highlight Translational Challenges for Liver-directed AAV8-mediated Gene TherapyMolecular Therapy, 2010
- Molecular Analysis of Vector Genome Structures After Liver Transduction by Conventional and Self-Complementary Adeno-Associated Viral Serotype Vectors in Murine and Nonhuman Primate ModelsHuman Gene Therapy, 2010
- Enhancement of Adeno-Associated Virus Infection by Mobilizing Capsids into and Out of the NucleolusJournal of Virology, 2009
- Identification of Cellular Proteins That Maintain Retroviral Epigenetic Silencing: Evidence for an Antiviral ResponseJournal of Virology, 2008
- Enhanced Response to Enzyme Replacement Therapy in Pompe Disease after the Induction of Immune ToleranceThe American Journal of Human Genetics, 2007
- Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liverBlood, 2007
- Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transferBlood, 2007
- Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouseProceedings of the National Academy of Sciences, 2007
- Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcriptsNature, 2003